Phase II study of ZYN002 in pediatric and adolescent patients with developmental and epileptic encephalopathies.
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2018
At a glance
- Drugs Cannabidiol (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 09 Jan 2018 New trial record
- 03 Jan 2018 According to Zynerba Pharmaceuticals media release, company will initiate this trial in the first half of 2018.